<DOC>
	<DOCNO>NCT01162161</DOCNO>
	<brief_summary>In mono-center prospective study , impact change sphingolipid metabolism patient pulmonary edema investigate .</brief_summary>
	<brief_title>Role Sphingolipids Pulmonary Edema</brief_title>
	<detailed_description>There three group patient : 1. hydrostatic pulmonary edema 2. toxic pulmonary edema 3. ventilate patient without pulmonary edema Samples routine bronchoalveolar lavage EDTA-blood analyse respect sphingolipids , ceramide , sphingomyelin-phosphodiesterase several cytokine .</detailed_description>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Pulmonary Edema</mesh_term>
	<criteria>age 18 taking steroid</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>sphingolipid</keyword>
	<keyword>ceramide</keyword>
	<keyword>sphingomyelinase</keyword>
</DOC>